Hospital Universitario Morales Meseguer

Murcia 30008

1 studies enrolling now · 5 studies all time

What they study most

Congenital Antithrombin Deficiency, Gastric Adenocarcinoma, Peripheral T-cell Lymphoma, Refractory Metastatic Gastric Cancer, Triple Negative Breast Cancer

Studies at this site

• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) — Recruiting now
• Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery — Recruiting now
• Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer — Completed
• Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma — Completed
• Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma — Completed